Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis
- PMID: 25516497
- PMCID: PMC4470874
- DOI: 10.1111/1471-0528.13201
Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis
Abstract
Objective: Smoking and pre-eclampsia (PE) are associated with increases in preterm birth, placental abruption and low birthweight. We evaluated the relationship between prenatal vitamin C and E (C/E) supplementation and perinatal outcomes by maternal self-reported smoking status focusing on outcomes known to be impacted by maternal smoking.
Design/setting/population: A secondary analysis of a multi-centre trial of vitamin C/E supplementation starting at 9-16 weeks in low-risk nulliparous women with singleton gestations.
Methods: We examined the effect of vitamin C/E by smoking status at randomisation using the Breslow-Day test for interaction.
Main outcome measures: The trial's primary outcomes were PE and a composite outcome of pregnancy-associated hypertension (PAH) with serious adverse outcomes. Perinatal outcomes included preterm birth and abruption.
Results: There were no differences in baseline characteristics within subgroups (smokers versus nonsmokers) by vitamin supplementation status. The effect of prenatal vitamin C/E on the risk of PE (P = 0.66) or PAH composite outcome (P = 0.86) did not differ by smoking status. Vitamin C/E was protective for placental abruption in smokers (relative risk [RR] 0.09; 95% CI 0.00-0.87], but not in nonsmokers (RR 0.92; 95% CI 0.52-1.62) (P = 0.01), and for preterm birth in smokers (RR 0.76; 95% CI 0.58-0.99) but not in nonsmokers (RR 1.03; 95% CI 0.90-1.17) (P = 0.046).
Conclusion: In this cohort of women, smoking was not associated with a reduction in PE or the composite outcome of PAH. Vitamin C/E supplementation appears to be associated with a reduction in placental abruption and preterm birth among smokers.
Keywords: Placental abruption; preterm birth; smoking.
© 2014 Royal College of Obstetricians and Gynaecologists.
Conflict of interest statement
Similar articles
-
PP170. Prenatal vitamin C and E supplementation is associated with a reduction in placental abruption and preterm birth in smokers.Pregnancy Hypertens. 2012 Jul;2(3):331-2. doi: 10.1016/j.preghy.2012.04.281. Epub 2012 Jun 13. Pregnancy Hypertens. 2012. PMID: 26105491
-
Vitamin C supplementation in pregnancy.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD004072. doi: 10.1002/14651858.CD004072.pub3. Cochrane Database Syst Rev. 2015. PMID: 26415762 Free PMC article. Review.
-
BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy.BMC Pregnancy Childbirth. 2020 Apr 21;20(1):234. doi: 10.1186/s12884-020-02935-7. BMC Pregnancy Childbirth. 2020. PMID: 32316938 Free PMC article. Clinical Trial.
-
Low-dose aspirin, smoking status, and the risk of spontaneous preterm birth.Am J Perinatol. 2015 Apr;32(5):445-50. doi: 10.1055/s-0034-1390352. Epub 2014 Sep 27. Am J Perinatol. 2015. PMID: 25261702 Clinical Trial.
-
Vitamin E supplementation in pregnancy.Cochrane Database Syst Rev. 2015 Sep 7;2015(9):CD004069. doi: 10.1002/14651858.CD004069.pub3. Cochrane Database Syst Rev. 2015. PMID: 26343254 Free PMC article. Review.
Cited by
-
Effects of Benzo[a]pyrene-DNA adducts, dietary vitamins, folate, and carotene intakes on preterm birth: a nested case-control study from the birth cohort in China.Environ Health. 2022 May 6;21(1):48. doi: 10.1186/s12940-022-00859-7. Environ Health. 2022. PMID: 35513839 Free PMC article.
-
Effects of Maternal Nutritional Supplements and Dietary Interventions on Placental Complications: An Umbrella Review, Meta-Analysis and Evidence Map.Nutrients. 2021 Jan 30;13(2):472. doi: 10.3390/nu13020472. Nutrients. 2021. PMID: 33573262 Free PMC article. Review.
-
Role of Palm Oil Vitamin E in Preventing Pre-eclampsia: A Secondary Analysis of a Randomized Clinical Trial Following ISSHP Reclassification.Front Med (Lausanne). 2021 Jan 21;7:596405. doi: 10.3389/fmed.2020.596405. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33553199 Free PMC article.
-
Fat-soluble nutrients and Omega-3 fatty acids as modifiable factors influencing preterm birth risk.Placenta. 2020 Sep 1;98:38-42. doi: 10.1016/j.placenta.2019.12.002. Epub 2019 Dec 5. Placenta. 2020. PMID: 33039030 Free PMC article. Review.
-
Smoking cessation in pregnancy: a continuing challenge in the United States.Ther Adv Drug Saf. 2018 May 28;9(8):457-474. doi: 10.1177/2042098618775366. eCollection 2018 Aug. Ther Adv Drug Saf. 2018. PMID: 30364850 Free PMC article. Review.
References
-
- Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2004;6 (Suppl 2):S125–40. - PubMed
-
- Cnattingius S, Granath F, Petersson G, Harlow BL. The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries. The New England journal of medicine. 1999;341:943–8. - PubMed
-
- Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. American journal of obstetrics and gynecology. 2005;192:1856–62. discussion 62–3. - PubMed
-
- Clark KE, Irion GL. Fetal hemodynamic response to maternal intravenous nicotine administration. American journal of obstetrics and gynecology. 1992;167:1624–31. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HD36801/HD/NICHD NIH HHS/United States
- U10 HD040500/HD/NICHD NIH HHS/United States
- UG1 HD027869/HD/NICHD NIH HHS/United States
- U10 HD034136/HD/NICHD NIH HHS/United States
- U10 HD040485/HD/NICHD NIH HHS/United States
- HD40485/HD/NICHD NIH HHS/United States
- HD40560/HD/NICHD NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- U10 HD040560/HD/NICHD NIH HHS/United States
- U10 HD040512/HD/NICHD NIH HHS/United States
- U01 HD036801/HD/NICHD NIH HHS/United States
- U10 HD053118/HD/NICHD NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- U10 HD040544/HD/NICHD NIH HHS/United States
- UL1 TR002548/TR/NCATS NIH HHS/United States
- UL1 RR024153/RR/NCRR NIH HHS/United States
- UG1 HD034116/HD/NICHD NIH HHS/United States
- HD27869/HD/NICHD NIH HHS/United States
- HD34136/HD/NICHD NIH HHS/United States
- UG1 HD040560/HD/NICHD NIH HHS/United States
- HD53118/HD/NICHD NIH HHS/United States
- UG1 HD053097/HD/NICHD NIH HHS/United States
- HD27860/HD/NICHD NIH HHS/United States
- UG1 HD027915/HD/NICHD NIH HHS/United States
- HD40512/HD/NICHD NIH HHS/United States
- UG1 HD040544/HD/NICHD NIH HHS/United States
- UG1 HD034208/HD/NICHD NIH HHS/United States
- M01 RR00080/RR/NCRR NIH HHS/United States
- UG1 HD040512/HD/NICHD NIH HHS/United States
- HD40545/HD/NICHD NIH HHS/United States
- U10 HD034116/HD/NICHD NIH HHS/United States
- HD21410/HD/NICHD NIH HHS/United States
- U10 HD027869/HD/NICHD NIH HHS/United States
- U10 HD027917/HD/NICHD NIH HHS/United States
- HD34116/HD/NICHD NIH HHS/United States
- U10 HD027915/HD/NICHD NIH HHS/United States
- UG1 HD040545/HD/NICHD NIH HHS/United States
- UG1 HD040485/HD/NICHD NIH HHS/United States
- U10 HD027860/HD/NICHD NIH HHS/United States
- HD40500/HD/NICHD NIH HHS/United States
- U10 HD034208/HD/NICHD NIH HHS/United States
- U10 HD053097/HD/NICHD NIH HHS/United States
- HD34208/HD/NICHD NIH HHS/United States
- HD27915/HD/NICHD NIH HHS/United States
- UG1 HD040500/HD/NICHD NIH HHS/United States
- HD27917/HD/NICHD NIH HHS/United States
- U10 HD021410/HD/NICHD NIH HHS/United States
- M01 RR000080/RR/NCRR NIH HHS/United States
- U24 HD036801/HD/NICHD NIH HHS/United States
- U10 HD036801/HD/NICHD NIH HHS/United States
- HD53097/HD/NICHD NIH HHS/United States
- U10 HD040545/HD/NICHD NIH HHS/United States
- HD40544/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical